OFLX (Omega Flex, Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by OFLX officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-13 | Dean W. Rivest | Chief Executive Officer | Buy | — | — |
| 2026-02-23 | Matthew Francis Unger | Vice President - CFO | MIXED | — | — |
| 2026-02-23 | Dean W. Rivest | Chief Executive Officer | MIXED | — | — |
| 2026-02-23 | Edwin B. Moran | President | MIXED | — | — |
| 2026-02-19 | Susan B. Asch | VP, General Counsel, Secretary | A | — | — |
| 2026-02-19 | Dean W. Rivest | Chief Executive Officer | A | — | — |
| 2026-02-19 | Matthew Francis Unger | Vice President - CFO | A | — | — |
| 2026-02-19 | Dean W. Rivest | Chief Executive Officer | A | — | — |
| 2026-02-19 | Edwin B. Moran | President | A | — | — |
| 2025-12-12 | David K Evans | Director | Buy | — | — |
| 2025-12-12 | STEWART B REED | Director | G | — | — |
| 2025-12-08 | STEPHEN M SHEA | Director | Buy | — | — |
| 2025-11-24 | Edwin B. Moran | President | Buy | — | — |
| 2025-06-12 | Kevin R Hoben | Executive Chairman | Sell | — | — |
| 2025-05-06 | Edwin B. Moran | President | Buy | — | — |
| 2025-02-24 | Matthew Francis Unger | Vice President - CFO | A | — | — |
| 2025-02-24 | Susan B. Asch | VP, General Counsel, Secretary | A | — | — |
| 2025-02-24 | Edwin B. Moran | President | A | — | — |
| 2025-02-24 | Dean W. Rivest | Chief Executive Officer | A | — | — |
| 2025-02-19 | Edwin B. Moran | President | MIXED | — | — |
| 2025-02-19 | Dean W. Rivest | Chief Executive Officer | MIXED | — | — |
| 2024-12-31 | STEWART B REED | Director | G | — | — |
| 2024-03-26 | Estate of John E Reed | 10%+ Owner | W | — | — |
| 2024-03-26 | STEWART B REED | Director | W | — | — |
| 2024-03-21 | Edwin B. Moran | President | A | — | — |
| 2024-03-21 | Matthew Francis Unger | Vice President - CFO | A | — | — |
| 2024-03-21 | Susan B. Asch | VP, General Counsel, Secretary | A | — | — |
| 2024-03-21 | Dean W. Rivest | Chief Executive Officer | A | — | — |
| 2024-02-29 | Edwin B. Moran | President | MIXED | — | — |
| 2024-02-29 | Dean W. Rivest | Chief Executive Officer | MIXED | — | — |
| 2023-12-18 | STEWART B REED | Director | G | — | — |
| 2023-09-06 | Kevin R Hoben | Chairman and CEO | G | — | — |
| 2023-06-14 | Kevin R Hoben | Chairman and CEO | G | — | — |
| 2023-06-14 | Kevin R Hoben | Chairman and CEO | G | — | — |
| 2023-03-29 | STEWART B REED | Director | G | — | — |
| 2023-03-09 | Dean W. Rivest | President | A | — | — |
| 2023-03-09 | Matthew Francis Unger | Vice President - CFO | A | — | — |
| 2023-03-09 | Edwin B. Moran | Executive Vice President | A | — | — |
| 2023-02-17 | Dean W. Rivest | President | MIXED | — | — |
| 2023-02-16 | Timothy P. Scanlan | Secretary | MIXED | — | — |
| 2023-02-16 | Edwin B. Moran | Executive Vice President | MIXED | — | — |
| 2023-02-01 | STEWART B REED | Director | Sell | — | — |
| 2022-08-22 | Mark F Albino | Director | Sell | — | — |
| 2022-08-19 | Mark F Albino | Director | Sell | — | — |
| 2022-08-18 | Mark F Albino | Director | Sell | — | — |
| 2022-08-18 | Mark F Albino | Director | Sell | — | — |
| 2022-08-18 | Mark F Albino | Director | Sell | — | — |
| 2022-08-17 | Mark F Albino | Director | Sell | — | — |
| 2022-08-17 | Mark F Albino | Director | Sell | — | — |
| 2022-08-17 | Mark F Albino | Director | Sell | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Executive Chairman | 898,873 | — |
| — | Director | 783,194 | — |
| — | Director | 192,401 | — |
| — | Director | 7,000 | — |
| — | Director | 4,100 | — |
| — | Director | 3,750 | — |
| — | Chief Executive Officer | 3,487 | — |
| — | Director | 2,210 | — |
| — | Director | 2,150 | — |
| — | Director | 1,850 | — |
| — | Vice President-Finance | 1,000 | — |
| — | Director | 906 | — |
| — | President | 899 | — |
| — | Director | 500 | — |
| — | Vice President - CFO | 395 | — |
| — | Secretary | 250 | — |
| — | VP & CFO | 50 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the OFLX quote page; the site-wide leaderboard is on the insider transactions hub.